ATE493152T1 - Liposomale kontrastmittel für die cest-bildgebung - Google Patents

Liposomale kontrastmittel für die cest-bildgebung

Info

Publication number
ATE493152T1
ATE493152T1 AT05801399T AT05801399T ATE493152T1 AT E493152 T1 ATE493152 T1 AT E493152T1 AT 05801399 T AT05801399 T AT 05801399T AT 05801399 T AT05801399 T AT 05801399T AT E493152 T1 ATE493152 T1 AT E493152T1
Authority
AT
Austria
Prior art keywords
contrast agents
cest imaging
liposomal contrast
liposomal
contrast agent
Prior art date
Application number
AT05801399T
Other languages
English (en)
Inventor
Marc Port
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Application granted granted Critical
Publication of ATE493152T1 publication Critical patent/ATE493152T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT05801399T 2004-09-23 2005-09-23 Liposomale kontrastmittel für die cest-bildgebung ATE493152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61217304P 2004-09-23 2004-09-23
PCT/EP2005/054798 WO2006032705A2 (en) 2004-09-23 2005-09-23 Contrast agents encapsulating systems for cest imaging

Publications (1)

Publication Number Publication Date
ATE493152T1 true ATE493152T1 (de) 2011-01-15

Family

ID=35871207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05801399T ATE493152T1 (de) 2004-09-23 2005-09-23 Liposomale kontrastmittel für die cest-bildgebung

Country Status (6)

Country Link
US (1) US20070292354A1 (de)
EP (1) EP1793868B1 (de)
JP (1) JP2008513533A (de)
AT (1) ATE493152T1 (de)
DE (1) DE602005025659D1 (de)
WO (1) WO2006032705A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116451A2 (en) 2005-04-22 2006-11-02 Morphotek, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
CN101166547B (zh) * 2005-04-26 2013-02-06 皇家飞利浦电子股份有限公司 包含cest活性的顺磁性配合物的mri造影剂
US7610077B2 (en) * 2005-12-08 2009-10-27 General Electric Compnay Quantitation of sample properties using contrast enhancement from saturation transfer
US20090142273A1 (en) * 2006-06-08 2009-06-04 Case Western Reserve University Activatable cest MRI agent
WO2007141767A2 (en) * 2006-06-09 2007-12-13 Koninklijke Philips Electronics N.V. Elimination of contrast agent concentration dependency in mri
NO20064315L (no) 2006-09-22 2008-03-24 Epitarget As T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav
ES2804801T3 (es) 2006-12-26 2021-02-09 Lantheus Medical Imaging Inc Ligandos para la formación de imágenes de la inervación cardíaca
FR2914304B1 (fr) 2007-03-28 2012-11-16 Guerbet Sa Composes pour le diagnostic de maladies liees a l'expression de vcam.
FR2914303A1 (fr) * 2007-03-28 2008-10-03 Guerbet Sa Composes pour le diagnostic de l'apoptose.
CA2682726C (en) 2007-04-05 2017-05-09 Morphotek, Inc. Methods for inhibiting the binding of endosialin to ligands
EP2065058A1 (de) * 2007-11-28 2009-06-03 Koninklijke Philips Electronics N.V. Nicht kugelförmige Kontrastmittel für CEST-MRI auf der Basis des magnetischen Bulk-Suszeptibilitätseffekts
EP2067490A1 (de) * 2007-12-07 2009-06-10 Koninklijke Philips Electronics N.V. Chelatbildnerderivate und diese enthaltende Zusammensetzungen zur Verwendung bei Bildgebungsverfahren
EP2067485A1 (de) * 2007-12-07 2009-06-10 Koninklijke Philips Electronics N.V. Wirkstoffträger zur Verbesserung des MRI-Kontrastes
CN101888857A (zh) * 2007-12-07 2010-11-17 皇家飞利浦电子股份有限公司 用于图像引导的递送的聚合物药物载体
JP5604432B2 (ja) * 2008-09-10 2014-10-08 コーニンクレッカ フィリップス エヌ ヴェ Ｍｒｉコントラスト強化薬物キャリア
FR2939318B1 (fr) * 2008-12-10 2012-07-13 Guerbet Sa Systeme d'encapsulation pour imagerie cest avec quelate q superieur ou egal a 2
KR20170042373A (ko) * 2010-05-11 2017-04-18 랜티우스 메디컬 이메징, 인크. 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
US12097269B2 (en) * 2010-10-27 2024-09-24 Vikas Kundra Dual mode gadolinium nanoparticle contrast agents
EP2457594A1 (de) * 2010-11-05 2012-05-30 Bracco Imaging S.p.A CEST-Systeme mit konzentrationsunabhängiger Ansprechempfindlichkeit
PL2694116T3 (pl) * 2011-04-06 2018-12-31 Board Of Regents Of The University Of Texas System Nanocząstki na bazie lipidów
US11246949B2 (en) * 2011-05-11 2022-02-15 The Research Foundation For The State University Of New York Imaging contrast agents and uses thereof
EP3567029A1 (de) 2011-09-09 2019-11-13 Lantheus Medical Imaging, Inc. Zusammensetzungen, verfahren und systeme zur synthese und verwendung von kontrastmitteln
JP6130401B2 (ja) 2012-01-20 2017-05-17 アンナプラガダ，アナンス 医学画像を客観的に特徴付けるための方法および組成物
US20150038435A1 (en) * 2012-03-01 2015-02-05 Novo Nordisk A/S N-terminally modified oligopeptides and uses thereof
PT2825156T (pt) 2012-03-16 2017-11-02 Merck Patent Gmbh Aminoácidos lipídicos de direcionamento
US20160022842A1 (en) 2013-03-11 2016-01-28 Wayne State University Formation and uses of europium
CA2951260C (en) * 2014-06-06 2023-02-28 Archer Daniels Midland Company Microemulsions and uses thereof
US9744251B2 (en) 2014-10-08 2017-08-29 Texas Children's Hospital MRI imaging of amyloid plaque using liposomes
NZ733669A (en) * 2015-01-23 2019-03-29 Helix Biopharma Corp Antibody-urease conjugates for therapeutic purposes
IL264363B2 (en) * 2016-07-25 2024-05-01 Wisconsin Alumni Res Found Radioactive phospholipid metal chelates for cancer imaging and therapy
CN109789207B (zh) * 2016-07-25 2022-11-18 威斯康星校友研究基金会 用于原位免疫调节的癌症疫苗接种的靶向放射治疗螯合物
DK3568205T3 (da) * 2017-01-12 2023-10-09 Radiomedix Inc Behandling af cancerceller, der overeksprimerer somatostatinreceptorer ved at anvende radioisotop-chelaterede ocreotid-derivater
WO2018167113A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag New bicyclic compounds as atx inhibitors
US11327000B2 (en) * 2018-05-21 2022-05-10 Saudi Arabian Oil Company Detecting saturation levels of a core sample using magnetic fields
CA3212963A1 (en) 2021-04-23 2022-10-27 Reinier HERNANDEZ Psma-targeting ligands with optimal properties for imaging and therapy
CN119424688B (zh) * 2025-01-10 2025-03-21 上海交通大学医学院附属仁济医院 一种基于叶酸的核磁共振成像对比剂的制备方法及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0442962B1 (de) * 1988-11-09 1994-01-05 UNGER, Evan C Liposomale radiologische kontrastmittel
US5242681A (en) * 1990-03-12 1993-09-07 Research Corporation Technologies, Inc. Lipophilic contrast agents for diagnostic image analysis
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
DE19505960A1 (de) * 1995-02-21 1996-08-22 Deutsches Krebsforsch Konjugat zur individuellen Dosierung von Arzneimitteln
DE69616453T2 (de) * 1995-02-24 2002-07-11 Bracco Research S.A., Plan-Les-Quates Liposomensuspensionen als blut-pool-kontrastmittel
US5707605A (en) * 1995-06-02 1998-01-13 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US5804164A (en) * 1996-03-13 1998-09-08 Research Corporation Technologies, Inc. Water-soluble lipophilic contrast agents
US6045774A (en) * 1997-01-10 2000-04-04 Epicyte Pharmaceutical Inc. J chain polypeptide targeting molecule linked to an imaging agent
CN1256634A (zh) * 1997-03-18 2000-06-14 赤池敏宏 识别微小环境变化的mri造影剂
CA2333927A1 (en) * 1998-04-01 1999-10-07 Dupont Pharmaceuticals Company Pyrimidines and triazines as integrin antagonists
AU3119199A (en) * 1998-04-03 1999-10-25 Du Pont Pharmaceuticals Company Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
CA2727746A1 (en) * 1998-12-18 2000-06-22 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
ES2321054T3 (es) * 1999-01-19 2009-06-02 Molecular Insight Pharmaceuticals, Inc. Conjugados de factores estimulantes de colonias de granulocitos para direccionamiento y formacion de imagenes de infeccion e inflamacion.
US6534038B2 (en) * 2000-04-07 2003-03-18 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
EP1390079A2 (de) * 2000-11-20 2004-02-25 Board of Regents University of Texas System Paramagnetischen metallion-basierte makrozyklische kontrastmitteln
EP1337278A2 (de) * 2000-11-27 2003-08-27 Bristol-Myers Squibb Medical Imaging, Inc. Gleichzeitiges imaging der kardialen perfusion und eines auf den vitronektin rezeptor zielgerichteten agens
US6517814B2 (en) * 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
US6562319B2 (en) * 2001-03-12 2003-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
EP1331012A1 (de) * 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Magnetisch beeinflussbare paramagnetische Kontrastmittel für Magnetresonanzbildgebung
US6869591B2 (en) * 2002-03-26 2005-03-22 Barnes-Jewish Hospital Paramagnetic particles that provide improved relaxivity
US7672704B2 (en) * 2002-09-11 2010-03-02 Duke University Methods and compositions for blood pool identification, drug distribution quantification and drug release verification
EP1466629A1 (de) * 2003-04-11 2004-10-13 BRACCO IMAGING S.p.A. Adducte zwischen NMR Vershibungsreagenzen und Substraten mit austauschbaren Protonen für die "CEST" Anwendung
FR2856689A1 (fr) * 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
CN101166547B (zh) * 2005-04-26 2013-02-06 皇家飞利浦电子股份有限公司 包含cest活性的顺磁性配合物的mri造影剂

Also Published As

Publication number Publication date
JP2008513533A (ja) 2008-05-01
DE602005025659D1 (de) 2011-02-10
US20070292354A1 (en) 2007-12-20
WO2006032705A2 (en) 2006-03-30
EP1793868A2 (de) 2007-06-13
WO2006032705A3 (en) 2006-12-21
EP1793868B1 (de) 2010-12-29

Similar Documents

Publication Publication Date Title
ATE493152T1 (de) Liposomale kontrastmittel für die cest-bildgebung
EP1664752A4 (de) Patientenpositionierungssystem für strahlentherapiesystem
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
DE60331055D1 (de) Retraktor für organe
MXPA05012463A (es) Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
EP1869873A4 (de) Auf standort basierende notansagen
EP2092767A4 (de) Bereitstellung standortbasierter dienste für mobile vorrichtungen
NO20041339L (no) Spiro-hydantoin-forbindelser anvendelige som anti-inflammatoriske midler
EP1940427A4 (de) Verkapselungssystem
EP2117251A4 (de) Realisierungsverfahren für notrufregistration
NO20070211L (no) Kationiske polymerer som inneholder 2-hydroksyetyl-metakrylsyre som akseleratorer for ASA-liming
DE602005013921D1 (de) Hydrodynamische pumpkanäle für kegelrollenmeissel
DE602004021222D1 (de) Diffusionssystem
ZA200800303B (en) Isotopically substituted proton pump inhibitors
FI20011727A0 (fi) Avustettu GPS-paikannus
TW200509921A (en) Alkaline salts
DK1581760T3 (da) Anlæg til fremstilling af viklede, stive rörledninger
FR2889347B1 (fr) Systeme de diffusion sonore
ITMI20022730A1 (it) Metodo di gestione di chiamate di emergenza.
FR2872730B1 (fr) Malaxeur mobile tel que betonniere
EP1676194A4 (de) Digitales broadcast-nachrichtensystem
DE60234422D1 (de) Fluidretentionsanordnung für die iontophoretische abgabe
ATE510509T1 (de) Ausseraxiales ankerführungssystem
ATE294148T1 (de) Chromatreduziertes hydraulisches bindemittel
SE0401679D0 (sv) GPS&BT Positioning

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties